Skyrizi

Skyrizi is a prescription medication used to treat plaque psoriasis in adults. 

Skyrizi belongs to a group of drugs called monoclonal antibodies that target specific molecules in the body known to play a role in disease. While the exact cause of plaque psoriasis is unknown, your body may produce too much of a protein called IL-23. IL-23 is one of several proteins that may contribute to excess inflammation inside the body, which can lead to painful, red, itchy, burning plaques on the skin. Skyrizi works by binding to excess IL-23. This can help reduce the inflammation inside the body that leads to plaques on the skin.

This medication is available in an injectable form to be given directly into the skin (subcutaneously).

Common side effects include upper respiratory infections, headache and tiredness.